Introduction and Aims: Change in estimated GFR (eGFR) is frequently used to track CKD progression in clinical practice, trials and cohort studies but its association with mortality has not been studied extensively. Methods: Change in eGFR was estimated as % change from the first to last eGFR (CKD-EPI creatinine) in a 2-year baseline period.We modeled the hazard ratios (HRs) of subsequent mortality as a spline function of % change in eGFR after adjusting for age, sex, race, first eGFR, and co-morbid conditions.We used random effects meta-analyses to combine results stratified by first baseline eGFR (<60 & ≥60) across studies. Results: Mortality follow-up of 1,597,723 participants from 32 cohorts for a mean of 3.7 years after the 2-year baseline period showed 101,120 deaths for baseline eGFR <60 (n=395,394) and 57,472 deaths for baseline eGFR ≥60 (n=1,202,329). Change in eGFR had a non-linear association with mortality (Figure for eGFR<60). A decline in eGFR was consistently associated with higher subsequent mortality risk (adjusted HR for -30% vs. 0% change in eGFR were: 1.8 at eGFR <60; and 1.6 at eGFR ≥60; p<0.001). Similar results were obtained for a 1- or 3-year change in eGFR. Hazards ratios were largely similar for those with eGFR ≥60 or when stratified by ACR levels. Conclusions: Declines in eGFR are strongly and consistently associated with subsequent risk of mortality adjusted for the first eGFR and covariates. These findings support using smaller changes than -57% (equivalent to doubling of serum creatinine) in clinical research.

DECLINE IN ESTIMATED GLOMERULAR FILTRATION RATE AND SUBSEQUENT RISK OF MORTALITY: A META-ANALYSIS OF 35 COHORTS IN THE CKD PROGNOSIS CONSORTIUM / Turin, Tc; Matsushita, K; Coresh, J; Arima, H; Chadban, Sj; Cirillo, M; Djurdjev, O; Green, Ja; Irie, F; Ix, Jh; Kovesdy, Cp; Ohkubo, T; Shankar, A; Wen, Cp; De Jong, Pe; Iseki, K; StengelB and Gansevoort, Rt; Chronic Kidney Disease Prognosis, Consortium. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 29:Suppl 3(2014), pp. iii54-iii54. [10.1093/ndt/gfu134]

DECLINE IN ESTIMATED GLOMERULAR FILTRATION RATE AND SUBSEQUENT RISK OF MORTALITY: A META-ANALYSIS OF 35 COHORTS IN THE CKD PROGNOSIS CONSORTIUM

Cirillo M;
2014

Abstract

Introduction and Aims: Change in estimated GFR (eGFR) is frequently used to track CKD progression in clinical practice, trials and cohort studies but its association with mortality has not been studied extensively. Methods: Change in eGFR was estimated as % change from the first to last eGFR (CKD-EPI creatinine) in a 2-year baseline period.We modeled the hazard ratios (HRs) of subsequent mortality as a spline function of % change in eGFR after adjusting for age, sex, race, first eGFR, and co-morbid conditions.We used random effects meta-analyses to combine results stratified by first baseline eGFR (<60 & ≥60) across studies. Results: Mortality follow-up of 1,597,723 participants from 32 cohorts for a mean of 3.7 years after the 2-year baseline period showed 101,120 deaths for baseline eGFR <60 (n=395,394) and 57,472 deaths for baseline eGFR ≥60 (n=1,202,329). Change in eGFR had a non-linear association with mortality (Figure for eGFR<60). A decline in eGFR was consistently associated with higher subsequent mortality risk (adjusted HR for -30% vs. 0% change in eGFR were: 1.8 at eGFR <60; and 1.6 at eGFR ≥60; p<0.001). Similar results were obtained for a 1- or 3-year change in eGFR. Hazards ratios were largely similar for those with eGFR ≥60 or when stratified by ACR levels. Conclusions: Declines in eGFR are strongly and consistently associated with subsequent risk of mortality adjusted for the first eGFR and covariates. These findings support using smaller changes than -57% (equivalent to doubling of serum creatinine) in clinical research.
2014
DECLINE IN ESTIMATED GLOMERULAR FILTRATION RATE AND SUBSEQUENT RISK OF MORTALITY: A META-ANALYSIS OF 35 COHORTS IN THE CKD PROGNOSIS CONSORTIUM / Turin, Tc; Matsushita, K; Coresh, J; Arima, H; Chadban, Sj; Cirillo, M; Djurdjev, O; Green, Ja; Irie, F; Ix, Jh; Kovesdy, Cp; Ohkubo, T; Shankar, A; Wen, Cp; De Jong, Pe; Iseki, K; StengelB and Gansevoort, Rt; Chronic Kidney Disease Prognosis, Consortium. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 29:Suppl 3(2014), pp. iii54-iii54. [10.1093/ndt/gfu134]
File in questo prodotto:
File Dimensione Formato  
2014 NDT 29(Suppl 3), iii54 abstract congresso.pdf

non disponibili

Dimensione 56.98 kB
Formato Adobe PDF
56.98 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/733136
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact